Clinical Efficacy and Quality of Life Assessment of Partial Cystectomy and Plasmakinetic Transurethral Resection of Tumor in Bladder Cancer Patients

References

• Jordan B, Meeks JJ. T1 bladder cancer: current considerations for diagnosis and management. Nat Rev Urol. 2019;16(1):23–34. doi:10.1038/s41585-018-0105-y
   PubMed Web of Science ®Google Scholar
• Lenis AT, Lec PM, Chamie K. Bladder cancer: a review. JAMA. 2020;324(19):1980–1991. doi:10.1001/jama.2020.17598
   PubMed Web of Science ®Google Scholar
• Wu P, Zhang G, Zhao J, et al. Profiling the urinary microbiota in male patients with bladder cancer in China. Front Cell Infect Microbiol. 2018;8:167. doi:10.3389/fcimb.2018.00167
   PubMed Web of Science ®Google Scholar
• Liu X, Jiang J, Yu C, et al. Secular trends in incidence and mortality of bladder cancer in China, 1990–2017: a joinpoint and age-period-cohort analysis. Cancer Epidemiol. 2019;61:95–103. doi:10.1016/j.canep.2019.05.011
   PubMed Web of Science ®Google Scholar
• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Malats N, Real FX. Epidemiology of bladder cancer. Hematol Oncol Clin. 2015;29(2):177–189. doi:10.1016/j.hoc.2014.10.001
   PubMed Web of Science ®Google Scholar
• Guidance N. Bladder cancer: diagnosis and management of bladder cancer. BJU Int. 2017;120(6):755–765.
   PubMed Web of Science ®Google Scholar
• Recchia F, Candeloro G, Desideri G, et al. Triple‐negative breast cancer: multipronged approach, single‐arm pilot Phase II study. Cancer Med. 2012;1(1):89–95. doi:10.1002/cam4.3
   PubMed Web of Science ®Google Scholar
• Cumberbatch MGK, Jubber I, Black PC, et al. Epidemiology of bladder cancer: a systematic review and contemporary update of risk factors in 2018. Eur Urol. 2018;74(6):784–795. doi:10.1016/j.eururo.2018.09.001
   PubMed Web of Science ®Google Scholar
• Farling KB. Bladder cancer: risk factors, diagnosis, and management. Nurse Pract. 2017;42(3):26–33. doi:10.1097/01.NPR.0000512251.61454.5c
   PubMed Web of Science ®Google Scholar
• Sanli O, Dobruch J, Knowles MA, et al. Bladder cancer. Nat Rev Dis Primers. 2017;3(1):1–19.
   Web of Science ®Google Scholar
• Feki-Tounsi M, Hamza-Chaffai A. Cadmium as a possible cause of bladder cancer: a review of accumulated evidence. Environ Sci Poll Res. 2014;21(18):10561–10573. doi:10.1007/s11356-014-2970-0
   PubMed Web of Science ®Google Scholar
• Koutros S, Decker KL, Baris D, et al. Bladder cancer risk associated with family history of cancer. Int J Cancer. 2021;148(12):2915–2923. doi:10.1002/ijc.33486
   PubMed Web of Science ®Google Scholar
• Woldu SL, Bagrodia A, Lotan Y. Guideline of guidelines–non-muscle invasive bladder cancer. BJU Int. 2017;119(3):371. doi:10.1111/bju.13760
   PubMed Web of Science ®Google Scholar
• Chang SS, Boorjian SA, Chou R, et al. Diagnosis and treatment of non-muscle invasive bladder cancer: AUA/SUO guideline. J Urol. 2016;196(4):1021–1029. doi:10.1016/j.juro.2016.06.049
   PubMed Web of Science ®Google Scholar
• Patel VG, Oh WK, Galsky MD. Treatment of muscle‐invasive and advanced bladder cancer in 2020. CA Cancer J Clin. 2020;70(5):404–423. doi:10.3322/caac.21631
   PubMed Web of Science ®Google Scholar
• Mirzaei S, Paskeh MDA, Hashemi F, et al. Long non-coding RNAs as new players in bladder cancer: lessons from pre-clinical and clinical studies. Life Sci;2021. 119948. doi:10.1016/j.lfs.2021.119948
   PubMed Web of Science ®Google Scholar
• Ashrafizadeh M, Zarrabi A, Samarghandian S, Najafi M. PTEN: what we know of the function and regulation of this onco-suppressor factor in bladder cancer? Eur J Pharmacol. 2020;881:173226. doi:10.1016/j.ejphar.2020.173226
   PubMed Web of Science ®Google Scholar
• Bilim V, Hoshi S. Prostatic urethra recurrence after transurethral resection of bladder tumor (TURBT) for non-muscle-invasive bladder cancer (NMIBC). Clin Case Rep. 2022;10(1):e05256. doi:10.1002/ccr3.5256
   Google Scholar
• Li K, Xu Y, Tan M, Xia S, Xu Z, Xu D. A retrospective comparison of thulium laser en bloc resection of bladder tumor and plasmakinetic transurethral resection of bladder tumor in primary non-muscle invasive bladder cancer. Lasers Med Sci. 2019;34(1):85–92. doi:10.1007/s10103-018-2604-8
   PubMed Web of Science ®Google Scholar
• Knoedler J, Frank I. Organ-sparing surgery in urology: partial cystectomy. Curr Opin Urol. 2015;25(2):111–115. doi:10.1097/MOU.0000000000000145
   PubMed Web of Science ®Google Scholar
• Mor V, Laliberte L, Morris JN, Wiemann M. The Karnofsky performance status scale: an examination of its reliability and validity in a research setting. Cancer. 1984;53(9):2002–2007. doi:10.1002/1097-0142(19840501)53:9<2002::AID-CNCR2820530933>3.0.CO;2-W
   PubMed Web of Science ®Google Scholar
• Shadpour P, Zamani M, Aghaalikhani N, Rashtchizadeh N. Inflammatory cytokines in bladder cancer. J Cell Physiol. 2019;234(9):14489–14499. doi:10.1002/jcp.28252
   PubMed Web of Science ®Google Scholar
• Backhaus J, Junghanns K, Broocks A, Riemann D, Hohagen F. Test–retest reliability and validity of the Pittsburgh Sleep Quality Index in primary insomnia. J Psychosom Res. 2002;53(3):737–740. doi:10.1016/S0022-3999(02)00330-6
   PubMed Web of Science ®Google Scholar
• Dunstan DA, Scott N. Norms for Zung’s self-rating anxiety scale. BMC Psychiatry. 2020;20(1):1–8. doi:10.1186/s12888-019-2427-6
   PubMed Web of Science ®Google Scholar
• Yue T, Li Q, Wang R, et al. Comparison of Hospital Anxiety and Depression Scale (HADS) and Zung Self-Rating Anxiety/Depression Scale (SAS/SDS) in evaluating anxiety and depression in patients with psoriatic arthritis. Dermatology. 2020;236(2):170–178. doi:10.1159/000498848
   PubMed Web of Science ®Google Scholar
• Devilliers H, Amoura Z, Besancenot J-F, et al. Responsiveness of the 36-item short form health survey and the Lupus Quality of Life questionnaire in SLE. Rheumatology. 2015;54(5):940–949. doi:10.1093/rheumatology/keu410
   PubMed Web of Science ®Google Scholar
• Hamad J, McCloskey H, Milowsky MI, Royce T, Smith A. Bladder preservation in muscle-invasive bladder cancer: a comprehensive review. Int Braz J Urol. 2020;46:169–184. doi:10.1590/s1677-5538.ibju.2020.99.01
   PubMed Web of Science ®Google Scholar
• Ericson KJ, Murthy PB, Bryk DJ, et al. Bladder-sparing treatment of nonmetastatic muscle-invasive bladder cancer. Clin Adv Hematol Oncol. 2019;17(12):697–707.
   PubMed Web of Science ®Google Scholar
• Abotaleb AA, Kandeel WS, Elmohamady B, Noureldin YA, El-Shaer W, Sebaey A. Bipolar plasma kinetic enucleation of non-muscle-invasive bladder cancer: initial experience with a novel technique. Arab J Urol. 2017;15(4):355–359. doi:10.1016/j.aju.2017.07.001
   PubMed Web of Science ®Google Scholar
• Jiang Y, Bai X, Zhang X, et al. Comparative study of the effectiveness and safety of transurethral bipolar plasmakinetic enucleation of the prostate and transurethral bipolar plasmakinetic resection of the prostate for massive benign prostate hyperplasia (> 80 mL). Med Sci Monitor. 2020;26:e921272–921271. doi:10.12659/MSM.921272
   PubMed Web of Science ®Google Scholar
• Peak TC, Hemal A. Partial cystectomy for muscle-invasive bladder cancer: a review of the literature. Transl Androl Urol. 2020;9(6):2938. doi:10.21037/tau.2020.03.04
   PubMed Web of Science ®Google Scholar
• Haider M, Ladurner C, Mayr R, et al. Use and duration of antibiotic prophylaxis and the rate of urinary tract infection after radical cystectomy for bladder cancer: results of a multicentric series. Paper presented at: Urologic Oncology: Seminars and Original Investigations 2019.
   Google Scholar
• Hirano T. IL-6 in inflammation, autoimmunity and cancer. Int Immunol. 2021;33(3):127–148. doi:10.1093/intimm/dxaa078
   PubMed Web of Science ®Google Scholar
• Patel HJ, Patel BM. TNF-α and cancer cachexia: molecular insights and clinical implications. Life Sci. 2017;170:56–63. doi:10.1016/j.lfs.2016.11.033
   PubMed Web of Science ®Google Scholar
• Alfaro C, Sanmamed MF, Rodríguez-Ruiz ME, et al. Interleukin-8 in cancer pathogenesis, treatment and follow-up. Cancer Treat Rev. 2017;60:24–31. doi:10.1016/j.ctrv.2017.08.004
   PubMed Web of Science ®Google Scholar
• Mannino MH, Zhu Z, Xiao H, Bai Q, Wakefield MR, Fang Y. The paradoxical role of IL-10 in immunity and cancer. Cancer Lett. 2015;367(2):103–107. doi:10.1016/j.canlet.2015.07.009
   PubMed Web of Science ®Google Scholar
• Habib EI, ElSheemy MS, Hossam A, et al. Holmium laser enucleation versus bipolar plasmakinetic resection for management of lower urinary tract symptoms in patients with large-volume benign prostatic hyperplasia: randomized-controlled trial. J Endourol. 2021;35(2):171–179. doi:10.1089/end.2020.0636
   PubMed Web of Science ®Google Scholar
• Cha EK, Donahue TF, Bochner BH. Radical transurethral resection alone, robotic or partial cystectomy, or extended lymphadenectomy: can we select patients with muscle invasion for less or more surgery? Urol Clin. 2015;42(2):189–199. doi:10.1016/j.ucl.2015.02.003
   PubMed Web of Science ®Google Scholar
• Akand M, Muilwijk T, Raskin Y, De Vrieze M, Joniau S, Van Der Aa F. Quality control indicators for transurethral resection of non–muscle-invasive bladder cancer. Clin Genitourin Cancer. 2019;17(4):e784–e792. (). doi:10.1016/j.clgc.2019.04.014
   PubMed Web of Science ®Google Scholar
• Luu DT, Duc NM, My T-T-T, Ly -T-T, Bang LV, Lenh B-V. Extraperitoneal bladder perforation secondary to transurethral resection of bladder tumor. Radiol Case Rep. 2021;16(4):811–814. doi:10.1016/j.radcr.2021.01.035
   PubMedGoogle Scholar